Mutations/deletions in separate genes, each of which alone causes a minimal phenotype, but when combined in the same cell results in a less severe fitness defect than expected under a given condition. This term is reserved for high or low throughput studies with scores.

Publication

Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.

Han K, Jeng EE, Hess GT, Morgens DW, Li A, Bassik MC

Identification of effective combination therapies is critical to address the emergence of drug-resistant cancers, but direct screening of all possible drug combinations is infeasible. Here we introduce a CRISPR-based double knockout (CDKO) system that improves the efficiency of combinatorial genetic screening using an effective strategy for cloning and sequencing paired single guide RNA (sgRNA) libraries and a robust statistical scoring ... [more]

Nat. Biotechnol. Mar. 20, 2017; 0(); [Pubmed: 28319085]

Quantitative Score

2.808 [Confidence Score]

Throughput

High Throughput

Ontology Terms

phenotype: growth abnormality (HP:0001507)

Additional Notes

CRISPR GI screen
Cell Line:K562 (EFO:0002067)
Experimental Setup:Timecourse
GIST: A-phenotypic positive genetic interaction
Library:Drug Target-CDKO CRISPRn library
Significance Threshold: q-value<0.05

Curated By

BioGRID

Interaction Summary

MAP3K5

Gene Ontology Biological Process

Gene Ontology Molecular Function

ATP binding [IDA]MAP kinase kinase kinase activity [IDA]cysteine-type endopeptidase activator activity involved in apoptotic process [IDA]magnesium ion binding [IDA]protein binding [IPI]protein homodimerization activity [IDA]protein kinase activity [IDA]protein phosphatase binding [IPI]

Gene Ontology Cellular Component

NPY4R